Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications

Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Shuiqin, Wang, Chenyu, Xiong, Jiachuan, Zhao, Jinghong, Yang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386414/
https://www.ncbi.nlm.nih.gov/pubmed/36157264
http://dx.doi.org/10.1159/000525090
_version_ 1784769804712804352
author Gong, Shuiqin
Wang, Chenyu
Xiong, Jiachuan
Zhao, Jinghong
Yang, Ke
author_facet Gong, Shuiqin
Wang, Chenyu
Xiong, Jiachuan
Zhao, Jinghong
Yang, Ke
author_sort Gong, Shuiqin
collection PubMed
description Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascular complications is still a big challenge for nephrologists, as satisfactory treatments are still lacking. Platelets, the second most abundant cells in the blood, are the major participants of hemostasis, thrombosis, and wound healing. In recent years, platelets have been reported in various physiological and pathological processes, including CKD and CKD-related CVDs.
format Online
Article
Text
id pubmed-9386414
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-93864142022-09-23 Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications Gong, Shuiqin Wang, Chenyu Xiong, Jiachuan Zhao, Jinghong Yang, Ke Kidney Dis (Basel) Review Article Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascular complications is still a big challenge for nephrologists, as satisfactory treatments are still lacking. Platelets, the second most abundant cells in the blood, are the major participants of hemostasis, thrombosis, and wound healing. In recent years, platelets have been reported in various physiological and pathological processes, including CKD and CKD-related CVDs. S. Karger AG 2022-06-03 /pmc/articles/PMC9386414/ /pubmed/36157264 http://dx.doi.org/10.1159/000525090 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Review Article
Gong, Shuiqin
Wang, Chenyu
Xiong, Jiachuan
Zhao, Jinghong
Yang, Ke
Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title_full Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title_fullStr Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title_full_unstemmed Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title_short Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
title_sort activated platelets, the booster of chronic kidney disease and cardiovascular complications
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386414/
https://www.ncbi.nlm.nih.gov/pubmed/36157264
http://dx.doi.org/10.1159/000525090
work_keys_str_mv AT gongshuiqin activatedplateletstheboosterofchronickidneydiseaseandcardiovascularcomplications
AT wangchenyu activatedplateletstheboosterofchronickidneydiseaseandcardiovascularcomplications
AT xiongjiachuan activatedplateletstheboosterofchronickidneydiseaseandcardiovascularcomplications
AT zhaojinghong activatedplateletstheboosterofchronickidneydiseaseandcardiovascularcomplications
AT yangke activatedplateletstheboosterofchronickidneydiseaseandcardiovascularcomplications

Ejemplares similares